Maturation of the hemostatic system during childhood.

The hemostatic system is assumed to be similar in children and adults and reference ranges established for adults are commonly used to evaluate children suspected of having congenital or acquired hemostatic problems. However, we know that the hemostatic system is not fully mature by 6 months of age and comprehensive studies of healthy older children have not been published. Therefore, we conducted a prospective cohort study of the hemostatic system in healthy children having minor, elective day surgery. After obtaining informed consent, a 3-mL blood sample was obtained at the time routine preoperative blood work was drawn. The plasma was fractioned and stored at -70 degrees C for batch assaying. We measured the concentration of 33 components of the hemostatic system (functional and immunologic assays) and the bleeding time (automated pediatric device) in 246 children aged 1 to 16 inclusive (a minimum of four subjects at each age). Eleven components of hemostasis (fibrinogen, prekallikrein, high-molecular weight kininogen, factors VIII and XIII, antithrombin III [ATIII], heparin cofactor II [HCII], alpha 1-antitrypsin [alpha 1AT], protein S, plasminogen, alpha 2-antiplasmin [alpha 2AP]) had mean values and ranges of normal that were similar to adults. Mean values of seven coagulants (II, V, VII, IX, X, XI, XII) were significantly lower than adult values and varied with age. Values for three inhibitors, alpha 2-macroglobulin (alpha 2M), protein C, and protein C1-inhibitor (C1-Inh) also differed from adults. Alpha 2M and C1-Inh inhibitor levels were elevated throughout childhood, whereas protein C levels were low, with a lower limit of normal of 0.40 U/mL until the age of 11. Finally, the upper limit of normal for the bleeding time was longer in children during the first 10 years of life, but decreased to adult values in the teenage years. In summary, there are important physiologic differences in the hemostatic system in children compared with adults. The decreased levels of several critical coagulants and increased levels of alpha 2M may contribute in part to the lower risk of thrombotic events in childhood. Age-matched controls should be used for evaluation of the hemostatic system in children with suspected congenital or acquired defects.

[1]  J. Strong,et al.  Acid mucopolysaccharides of human aorta , 1967 .

[2]  M. Lessard,et al.  Two Cases of Inherited Triple Deficiency in a Large Kindred with Thrombotic Diathesis and Deficiencies of Antithrombin III, Heparin Cofactor II, Protein C and Protein S , 1991, Thrombosis and Haemostasis.

[3]  A. Siegbahn,et al.  Age Dependence of Blood Fibrinolytic Components and the Effects of Low-Dose Oral Contraceptives on Coagulation and Fibrinolysis in Teenagers , 1988, Thrombosis and Haemostasis.

[4]  F. Ofosu,et al.  Thrombin Regulation in Mother and Fetus During Pregnancy , 1992, Seminars in thrombosis and hemostasis.

[5]  T. Shepard,et al.  The development of hemostasis in the human fetus and newborn infant. , 1971, The Journal of pediatrics.

[6]  A. Chuansumrit,et al.  Heparin cofactor II in adults and infants with thrombosis and DIC , 1989, American journal of hematology.

[7]  M. Nardi,et al.  Prothrombin and protein C in early childhood: normal adult levels are not achieved until the fourth year of life. , 1986, The Journal of pediatrics.

[8]  D. Alarcón-Segovia,et al.  Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin. , 1989, The Journal of rheumatology.

[9]  H. Hemker,et al.  The Relative Importance of the Factors II, VII, IX and X for the Prothrombinase Activity in Plasma of Orally Anticoagulated Patients , 1989, Thrombosis and Haemostasis.

[10]  F. Ofosu,et al.  Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. , 1991, Blood.

[11]  R. Bertina,et al.  Protein C Levels in Infancy and Early Childhood , 1987, Acta paediatrica Scandinavica.

[12]  B. Schmidt,et al.  Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin , 1990, Thrombosis and Haemostasis.

[13]  J. Cameron.  Coagulation and thromboembolic complications in the nephrotic syndrome. , 1984, Advances in nephrology from the Necker Hospital.

[14]  B. Scherstén,et al.  Serum α2-macroglobulin concentration and its variation with age and sex , 1967 .

[15]  J. Amiral,et al.  Vitamin K Dependent Proteins in Fetal Hemostasis at Mid Trimester of Pregnancy , 1985, Thrombosis and Haemostasis.

[16]  O. Montagna,et al.  POST‐NATAL DEVELOPMENT OF FACTOR IX , 1980, Acta paediatrica Scandinavica.

[17]  Y. Beuzard,et al.  Hematological Values of 163 Normal Fetuses between 18 and 30 Weeks of Gestation , 1986, Pediatric Research.

[18]  E. Ritz,et al.  Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. , 1987, The Journal of pediatrics.

[19]  S. Israels,et al.  Childhood stroke associated with protein C or S deficiency. , 1987, The Journal of pediatrics.

[20]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[21]  The Kinetics of Inhibition of Thrombin by Antithrombin in the Presence of Components of the Hemostatic System , 1985 .

[22]  K. Bauer,et al.  The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. , 1987, Blood.

[23]  J. Sanders,et al.  The bleeding time may be longer in children than in adults. , 1990, The American journal of pediatric hematology/oncology.

[24]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.

[25]  M. Wolf,et al.  Temporary protein C deficiency associated with cerebral arterial thrombosis in childhood. , 1988, The Journal of pediatrics.

[26]  R. Bertina,et al.  Two ELISA's for measurement of protein S, and their use in the laboratory diagnosis of protein S deficiency. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[27]  J. Lazarchick,et al.  Protein C deficiency as a cause of pulmonary embolism in the perioperative period. , 1991, Anesthesiology.

[28]  Hultin Mb.  Fibrinogen and factor VII as risk factors in vascular disease. , 1991 .

[29]  J. Jesty.  The kinetics of formation and dissociation of the bovine thrombin.antithrombin III complex. , 1979, The Journal of biological chemistry.

[30]  Boscoe M. Paes,et al.  Development of the Hemostatic System in the Neonate and Young Infant , 1990, The American journal of pediatric hematology/oncology.

[31]  G. Leone,et al.  Severe Deep Vein Thrombosis in a 2-Year-Old Child with Protein S Deficiency , 1987, Thrombosis and Haemostasis.

[32]  J. Corrigan,et al.  Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis , 1991, Thrombosis and Haemostasis.

[33]  A. Voller.  The enzyme-linked immunosorbent assay (ELISA) (theory, technique and applications). , 1978, La Ricerca in clinica e in laboratorio.

[34]  K. Nagasawa,et al.  The rate of the thrombin/antithrombin III reaction is determined with their molar ratio rather than their absolute concentrations. , 1987, Thrombosis research.

[35]  K. Bloch,et al.  Elevated levels of α2-macroglobulin-protease complexes in infants , 1987 .

[36]  K. Lechner,et al.  Antithrombin III deficiency and thromboembolism. , 1981, Clinics in haematology.

[37]  M. Aiach,et al.  Antithrombin III (ATIII) and Heparin Cofactor II (HCII) in Normal Human Fetuses (21st-27th Week) , 1986, Thrombosis and Haemostasis.

[38]  B. Schmidt,et al.  Alpha-2-Macroglobulin Is an Important Progressive Inhibitor of Thrombin in Neonatal and Infant Plasma , 1989, Thrombosis and Haemostasis.

[39]  C. Esmon,et al.  An abnormal plasma distribution of protein S occurs in functional protein S deficiency. , 1986, Blood.

[40]  W. Hathaway.  The bleeding newborn. , 1975, Seminars in hematology.

[41]  J. Hirsh,et al.  Venous thromboembolism : natural history, diagnosis, and management , 1987 .

[42]  R. Carrell,et al.  PROTEIN C DEFICIENCY AND PORTAL THROMBOSIS IN LIVER TRANSPLANTATION IN CHILDREN , 1988, The Lancet.

[43]  A. Rydzewski,et al.  Concentration of three thrombin inhibitors in the nephrotic syndrome in adults. , 1986, Nephron.

[44]  F. Ofosu,et al.  An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. , 1992, The Journal of clinical investigation.

[45]  H. Hillege,et al.  Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations , 1990, The Lancet.

[46]  A. Fischer,et al.  Respective Roles of Antithrombin III and Alpha 2 Macroglobulin in Thrombin Inactivation , 1981, Thrombosis and Haemostasis.